title: [Treatment of adult Ph-negative acute lymphoblastic leukemia].
authors.forename: Kiyotoshi
authors.initials: K
authors.lastname: Imai
mesh_terms: D000227:Adenine Nucleotides / Q000008:administration & dosage; D000293:Adolescent; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D001087:Arabinonucleosides / Q000008:administration & dosage; D001897:Boronic Acids / Q000008:administration & dosage; D000069286:Bortezomib; D000077866:Clofarabine; D003131:Combined Modality Therapy; D060830:Consolidation Chemotherapy; D006680:HLA Antigens; D018380:Hematopoietic Stem Cell Transplantation; D006648:Histocompatibility; D006801:Humans; D060828:Induction Chemotherapy; D060046:Maintenance Chemotherapy; D018365:Neoplasm, Residual; D010677:Philadelphia Chromosome; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000235:genetics* / Q000628:therapy*; D011719:Pyrazines / Q000008:administration & dosage; D012008:Recurrence; D019172:Transplantation Conditioning; D055815:Young Adult
chemical_list: D000227:Adenine Nucleotides; D001087:Arabinonucleosides; D001897:Boronic Acids; D006680:HLA Antigens; D011719:Pyrazines; C104457:nelarabine; D000069286:Bortezomib; D000077866:Clofarabine